Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Small Cell Lung Carcinoma × Afatinib × Thoracic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 58 Lung Neoplasms 10 Adenocarcinoma 3 Non-small-cell Lung Cancer With Somatic EGFR Mutations 2 Neoplasms 2 NSCLC 2 Adenocarcinoma of Lung 2 Thoracic Neoplasms 1 Squamous Non-small Cell Lung Cancer 1 Small Cell Lung Carcinoma 1 Respiratory Tract Neoplasms 1 Respiratory Tract Diseases 1 Pleural Neoplasms 1 Pleural Effusion, Malignant 1 Pleural Effusion 1 Pleural Diseases 1 Neoplasms by Site 1 NSCLC Harboring NRG1 Fusion 1 NRG1-fused Non-small Cell Lung Cancer 1 Mouth Neoplasms 1 Meningeal Neoplasms 1 Melanoma 1 Lung Diseases 1 EGFR Mutation Positive Non-small Cell Lung Cancer 1 Carcinoma, Transitional Cell 1 Carcinoma, Squamous Cell 1 Carcinoma, Bronchogenic 1 Cancers Harbouring an EGFR Mutation, (Excluding Non-squamous Non- Small Cell Lung Cancer, a Registered Indication), a HER2 Mutation or a HER3 Mutation 1 Breast Neoplasms 1 Brain Neoplasms 1

Interventions

Etoposide 137 Carboplatin 127 Cisplatin 95 Topotecan 68 durvalumab 50 atezolizumab 42 Irinotecan 42 pembrolizumab 32 Radiotherapy 30 Nivolumab 29 Paclitaxel 28 PM 01183 22 Drug Therapy 22 anlotinib 19 apatinib 18 Gemcitabine 18 Ipilimumab 17 Platinum 16 Docetaxel 15 olaparib 13 Radiosurgery 13 Bevacizumab 13 Pemetrexed 12 toripalimab 11 rovalpituzumab tesirine 11 Magnetic Resonance Spectroscopy 11 amrubicin 10 Temozolomide 10 trilaciclib 9 tremelimumab 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02876081 2017-09-11

THEN

Fondation Hôpital Saint-Joseph

Phase 2 Withdrawn

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡